SHARE:
Products sold on our website are designed for in vitro testing and lab experimentation exclusively.
All the products you see on the website are being sold in a lyophilized powder state (freeze-dried), in a sealed sterile vial; and should be reconstituted.
The product’s label clearly states the amount of product a vial contains; some products are offered in different variations.
The products we are selling come in a sealed vial but require additional lab equipment for proper testing.
PNC-27 is a synthetic peptide composed of 27 amino acids, designed as a derivative of the α-helical region of the tumor-suppressor protein p53 (ASPP2). It has been explored for its potential to affect the growth and survival of certain cancer cells.
Early findings indicate that PNC-27 may interact specifically with cancer cell membranes while leaving healthy cells largely unaffected. The peptide was first developed in 2000 during research related to immunodeficiency (HIV) and was found to bind to HDM2, a protein commonly overexpressed on the membranes of malignant cells. Unlike many experimental compounds that trigger apoptosis, PNC-27 appears to disrupt cancer cells through necrosis. This is thought to occur when the peptide forms pores in the cellular membrane, compromising its integrity and leading to ion imbalance, leakage of cellular contents, and eventual cell death.
Useful links